Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: Sep 28, 2011

Premium

Martin Madaus has been named Quanterix's permanent CEO. Madaus, who is chairman of the company, had been serving as interim CEO since May when David Okrongly left the Cambridge, Mass.-based company.

Madaus has served as a director of Quanterix since 2010, and became chairman of the firm last December. Prior to joining Quanterix, he served as president, chairman, and CEO of Millipore before it was acquired by Merck KGaA last year.


Former Solexa CEO John West has been named CEO of startup Personalis, a human genome analysis firm co-founded by West and Stanford University researchers Euan Ashley, Russ Altman, Atul Butte, and Mike Snyder.

Following Illumina's 2006 acquisition of Solexa, West served as senior vice president and general manager for Illumina's DNA sequencing business. Before joining Solexa as CEO in 2004, West was vice president of DNA platforms at Applied Biosystems.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.